FITCHBURG, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection molding, announced results for its third quarter ended September 30, 2015.
Salvatore Emma, Jr., President and CEO, commented, “Overall, net sales and earnings were lower due to decreased sensor sales volume. Additionally, the strength of the U.S. dollar impacted orders from some of our international sensor customers, which make up a majority of our sensor sales. We continue to pursue new opportunities to increase market share and reduce costs in our sensors business.”
Help employers find you! Check out all the jobs and post your resume.
